Chances are you—or someone you know—has dealt with Lyme disease. It often begins with a tick bite that goes unnoticed, followed by fatigue, joint pain, or brain fog. For many, the most troubling part comes after treatment. Antibiotics are taken, tests come back clear, yet symptoms linger. Despite standardized treatment, a significant number of patients never fully recover, leaving unanswered questions about lingering infection, immune response, or gaps in medical understanding.
An Overlooked Antibiotic Shakes Up the Lyme Disease Debate
